Cancer Updates
Cancer news from the American Cancer Society.
Filtering by:
ImmunotherapyFDA Approves First Drug for Cancers with a High Tumor Mutational Burden
Published on: June 18, 2020
The US Food and Drug Administration (FDA) has expanded the approval of the immunotherapy drug pembrolizumab (Keytruda) to include any cancer with a high tumor mutational burden (TMB-H).
FDA Approves Padcev (Enfortumab vedotin-ejfv) for Bladder Cancer
Published on: December 20, 2019
The US Food and Drug Administration (FDA) has approved a new type of drug for certain people with bladder cancer.
FDA Approves Tecentriq (Atezolizumab) for Small Cell Lung Cancer
Published on: March 19, 2019
The US Food and Drug Administration (FDA) has approved the immunotherapy drug Tecentriq (atezolizumab) for the treatment of small cell lung cancer (SCLC).
FDA Approves Immunotherapy for Breast Cancer
Published on: March 11, 2019
The US Food and Drug Administration today approved the first immunotherapy treatment for breast cancer. It approved a combination of Tecentriq (atezolizumab) and Abraxane (nab-paclitaxel) for people with advanced triple negative breast cancer.
Study Supports Immunotherapy for Treating Triple-Negative Breast Cancer
Published on: October 30, 2018
A study by an international group of researchers has found for the first time that a combination of immunotherapy and chemotherapy can extend lives of women with triple-negative breast cancer.